Put Options

22 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.0 - $5.55 $36,900 - $68,265
-12,300 Reduced 23.08%
41,000 $134,000
Q2 2024

Aug 15, 2024

BUY
$3.31 - $18.51 $16,550 - $92,550
5,000 Added 10.35%
53,300 $226,000
Q1 2024

May 07, 2024

BUY
$9.77 - $21.47 $471,891 - $1.04 Million
48,300 New
48,300 $710,000
Q2 2023

Aug 11, 2023

SELL
$4.62 - $7.54 $100,716 - $164,372
-21,800 Reduced 28.5%
54,700 $292,000
Q1 2023

May 16, 2023

BUY
$4.82 - $7.24 $368,730 - $553,860
76,500 New
76,500 $548,000
Q4 2021

Feb 14, 2022

SELL
$15.91 - $21.88 $315,018 - $433,224
-19,800 Reduced 42.67%
26,600 $427,000
Q3 2021

Nov 15, 2021

BUY
$19.74 - $28.7 $63,167 - $91,840
3,200 Added 7.41%
46,400 $972,000
Q2 2021

Aug 11, 2021

SELL
$20.49 - $35.63 $98,351 - $171,024
-4,800 Reduced 10.0%
43,200 $1.16 Million
Q1 2021

May 17, 2021

SELL
$18.99 - $33.2 $258,263 - $451,520
-13,600 Reduced 22.08%
48,000 $1.53 Million
Q4 2020

Feb 16, 2021

BUY
$19.41 - $26.0 $657,999 - $881,400
33,900 Added 122.38%
61,600 $1.41 Million
Q3 2020

Nov 16, 2020

SELL
$24.69 - $31.6 $646,878 - $827,920
-26,200 Reduced 48.61%
27,700 $698,000
Q2 2020

Aug 14, 2020

BUY
$5.2 - $29.12 $154,440 - $864,864
29,700 Added 122.73%
53,900 $1.51 Million
Q1 2020

May 15, 2020

SELL
$4.28 - $12.11 $56,068 - $158,641
-13,100 Reduced 35.12%
24,200 $141,000
Q4 2019

Feb 14, 2020

SELL
$7.95 - $12.27 $67,575 - $104,295
-8,500 Reduced 18.56%
37,300 $406,000
Q3 2019

Nov 14, 2019

BUY
$12.44 - $17.48 $166,696 - $234,232
13,400 Added 41.36%
45,800 $584,000
Q2 2019

Aug 14, 2019

SELL
$14.51 - $19.71 $385,966 - $524,286
-26,600 Reduced 45.08%
32,400 $550,000
Q1 2019

May 15, 2019

BUY
$11.11 - $25.6 $545,501 - $1.26 Million
49,100 Added 495.96%
59,000 $1.06 Million
Q3 2018

Nov 14, 2018

BUY
$19.26 - $23.46 $190,674 - $232,254
9,900 New
9,900 $212,000
Q2 2018

Aug 14, 2018

SELL
$19.78 - $24.67 $237,360 - $296,040
-12,000 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$18.89 - $32.46 $519,475 - $892,650
-27,500 Reduced 69.62%
12,000 $302,000
Q4 2017

Feb 14, 2018

BUY
$16.19 - $20.3 $161,900 - $203,000
10,000 Added 33.9%
39,500 $751,000
Q3 2017

Nov 14, 2017

BUY
$15.52 - $18.94 $457,840 - $558,730
29,500
29,500 $545,000

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $205M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.